Concentrations of remdesivir and GS-441524 in human milk from lactating individuals diagnosed with COVID-19

Kerri Bertrand; Yadira Sepulveda; Benjamin J Spiegel; Brookie M Best; Raymond Suhandynata; Steven Rossi; Christina D Chambers; Jeremiah D Momper

doi:10.1038/s41390-024-03053-2

Concentrations of remdesivir and GS-441524 in human milk from lactating individuals diagnosed with COVID-19

Pediatr Res. 2024 Feb 12. doi: 10.1038/s41390-024-03053-2. Online ahead of print.

Authors

Kerri Bertrand¹, Yadira Sepulveda², Benjamin J Spiegel², Brookie M Best^{3

2}, Raymond Suhandynata², Steven Rossi², Christina D Chambers^{3

4}, Jeremiah D Momper²

Affiliations

¹ Department of Pediatrics, University of California, San Diego, La Jolla, CA, 92093, USA. kdutcher@health.ucsd.edu.
² Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, 92093, USA.
³ Department of Pediatrics, University of California, San Diego, La Jolla, CA, 92093, USA.
⁴ Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, La Jolla, CA, 92093, USA.

PMID: 38347172
DOI: 10.1038/s41390-024-03053-2

Abstract

Findings from this study provide further reassuring evidence that infant exposure through human milk received from lactating individuals who require treatment with remdesivir is negligible.

Publication types

Letter